Previous studies have investigated ezrin protein expression in smaller cohorts of breast cancer patients, or patients with specific disease characteristics, such as triple‐negative disease, to show associations with clinical outcomes.5, 14, 15. This evidence concerns the gene EZR and breast carcinoma.